1 |
Dextran 1
| 1件: Dextran Dextran | 1件: Dextran Dextran; | - | - | 5件: 2 2, 62, 79, 96, 97 |
2 |
Dinoprostone
| - | 0件: | - | - | - |
3 |
Dinoprost
| - | 0件: | - | - | - |
4 |
Diflunisal
| 1件: Diflunisal Diflunisal | 1件: Diflunisal Diflunisal; | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 28 28 |
5 |
Disulfiram
| - | 0件: | - | - | - |
6 |
Dimercaprol
| 1件: Dimercaprol Dimercaprol | 0件: | - | - | 5件: 49 49, 51, 84, 85, 299 |
7 |
Dexpanthenol
| - | 0件: | - | - | - |
8 |
Dactinomycin
| - | 0件: | - | - | - |
9 |
Dacarbazine
| - | 0件: | - | - | - |
10 |
Danazol
| 1件: Danazol Danazol | 1件: Danazol Danazol; | 3件: AR AR, ESR1, PGR 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 5件: 60 60, 63, 64, 65, 285 |
11 |
Demeclocycline hydrochloride
| - | 0件: | - | - | - |
12 |
Desmopressin
| 1件: Desmopressin Desmopressin | 5件: DDAVP DDAVP; Desmopressin; Desmopressin acetate; Desmopressine; Minirin; | 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 6件: 6 6, 64, 72, 75, 225, 288 |
13 |
Dexamethasone
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
14 |
Diazepam
| 1件: Diazepam Diazepam | 1件: Diazepam Diazepam; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 46 46, 155, 298 |
15 |
Diazoxide
| 1件: Diazoxide Diazoxide | 1件: Diazoxide Diazoxide; | 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 2件: 13 13, 193 |
16 |
Didanosine
| 1件: Didanosine Didanosine | 1件: Didanosine Didanosine; | - | - | 2件: 25 25, 265 |
17 |
Digitoxin
| 1件: Digitoxin Digitoxin | 1件: Digitoxin Digitoxin; | 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
18 |
Digoxin
| 1件: Digoxin Digoxin | 1件: Digoxin Digoxin; | 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 8 8, 46, 210 |
19 |
Dihydrotachysterol
| 1件: Dihydrotachysterol Dihydrotachysterol | 0件: | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 2件: 6 6, 85 |
20 |
Diphenhydramine
| 1件: Diphenhydramine Diphenhydramine | 2件: Diphenhydramine Diphenhydramine; Diphenhydramine hydrochloride; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
21 |
Dipyridamole
| 1件: Dipyridamole Dipyridamole | 1件: Dipyridamole Dipyridamole; | 2件: PDE4A PDE4A, PDE5A 💬 | 6件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 46 46, 49, 51, 66, 96, 224 |
22 |
Disopyramide
| - | 0件: | - | - | - |
23 |
Dronabinol
| 1件: Dronabinol Dronabinol | 4件: DELTA-9-TETRAHYDROCANNABINOL DELTA-9-TETRAHYDROCANNABINOL; DRONABINOL; Sativex; Tetrahydrocannabinol; | 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 8件: 2 2, 8, 13, 36, 46, 96, 271, 298 |
24 |
Doxycycline
| 1件: Doxycycline Doxycycline | 4件: Doxycyclin Doxycyclin; DOXYCYCLINE; DOXYCYCLINE HYCLATE; Doxycycline Tablets; | - | - | 16件: 13 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
25 |
Droperidol
| - | 0件: | - | - | - |
26 |
Dexmedetomidine
| 1件: Dexmedetomidine Dexmedetomidine | 4件: Dexdor Dexdor; DEXMEDETOMIDINA; Dexmedetomidine; DEXMEDETOMIDINE HYDROCHLORIDE; | 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 13件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 |
27 |
Dichlorphenamide
| 1件: Diclofenamide Diclofenamide | 1件: Dichlorphenamide Dichlorphenamide; | 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 114 114 |
28 |
Dimenhydrinate
| - | 0件: | - | - | - |
29 |
Desflurane
| 1件: Desflurane Desflurane | 1件: Desflurane Desflurane; | - | - | 2件: 22 22, 296 |
30 |
Diethylstilbestrol
| - | 0件: | - | - | - |
31 |
Dapsone
| 1件: Dapsone Dapsone | 1件: Dapsone Dapsone; | - | - | 6件: 35 35, 42, 60, 84, 90, 162 |
32 |
Doxazosin mesylate
| 1件: Doxazosin Doxazosin | 2件: CARDURA CARDURA; DOXAZOSIN; | 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 57 57, 67 |
33 |
Diltiazem hydrochloride
| 1件: Diltiazem Diltiazem | 2件: Diltiazem Diltiazem; Diltiazem Hydrochloride; | 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 58, 86 |
34 |
Dobutamine hydrochloride
| 1件: Dobutamine Dobutamine | 2件: Dobutamin Dobutamin; Dobutamine; | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 57 57, 58, 215 |
35 |
Dopamine hydrochloride
| 1件: Dopamine Dopamine | 2件: Dopamina Dopamina; Dopamine; | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 4件: 6 6, 7, 74, 299 |
36 |
Disopyramide phosphate
| - | 0件: | - | - | - |
37 |
Dofetilide
| - | 0件: | - | - | - |
38 |
Dorzolamide hydrochloride
| 1件: Dorzolamide Dorzolamide | 1件: Dorzolamide Dorzolamide; | 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 90 90 |
39 |
Demecarium bromide
| - | 0件: | - | - | - |
40 |
Dexchlorpheniramine maleate
| 1件: Chlorpheniramine Chlorpheniramine | 1件: Clorfenamina Clorfenamina; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 14 14 |
41 |
Diphenhydramine hydrochloride
| 1件: Diphenhydramine Diphenhydramine | 2件: Diphenhydramine Diphenhydramine; Diphenhydramine hydrochloride; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
42 |
Donepezil hydrochloride
| 1件: Donepezil Donepezil | 3件: Aricept Aricept; Donepezil; Donepezil hydrochloride; | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 9件: 5 5, 6, 13, 46, 78, 124, 127, 156, 206 |
43 |
Dyphylline
| - | 0件: | - | - | - |
44 |
Dicyclomine hydrochloride
| - | 0件: | - | - | - |
45 |
Dolasetron mesylate
| - | 0件: | - | - | - |
46 |
Dibucaine
| - | 0件: | - | - | - |
47 |
Dyclonine hydrochloride
| - | 0件: | - | - | - |
48 |
Doxacurium chloride
| - | 0件: | - | - | - |
49 |
Diethylcarbamazine citrate
| - | 0件: | - | - | - |
50 |
Desipramine hydrochloride
| 1件: Desipramine Desipramine | 1件: Desipramine Desipramine; | 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 120 120, 156 |
51 |
Doxepin hydrochloride
| 1件: Doxepin Doxepin | 1件: Doxepin Doxepin; | 3件: HRH1 HRH1, SLC6A2, SLC6A4 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
52 |
Dehydroemetine
| - | 0件: | - | - | - |
53 |
Dezocine
| - | 0件: | - | - | - |
54 |
Dextromethorphan hydrobromide
| 1件: Dextromethorphan Dextromethorphan | 4件: Dextromethorphan Dextromethorphan; DEXTROMETHORPHAN HYDROBROMIDE; Dextrometorfano; Nuedexta; | 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
55 |
Dalfopristin
| - | 0件: | - | - | - |
56 |
Delavirdine mesylate
| - | 0件: | - | - | - |
57 |
Dienestrol
| - | 0件: | - | - | - |
58 |
Diclofenac potassium
| 1件: Diclofenac Diclofenac | 3件: Diclofenac Diclofenac; Diclofenac sodium; Diclofenac SR; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 5件: 13 13, 34, 46, 78, 271 |
59 |
Diclofenac sodium
| 1件: Diclofenac Diclofenac | 3件: Diclofenac Diclofenac; Diclofenac sodium; Diclofenac SR; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 5件: 13 13, 34, 46, 78, 271 |
60 |
Dexamethasone sodium phosphate
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
61 |
Doxercalciferol
| - | 0件: | - | - | - |
62 |
Diatrizoate sodium
| - | 0件: | - | - | - |
63 |
Dimethyl sulfoxide
| 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 2件: Dimethyl sulfoxide Dimethyl sulfoxide; DMSO; | - | - | 1件: 226 226 |
64 |
Daptomycin
| - | 0件: | - | - | - |
65 |
Doramectin
| - | 0件: | - | - | - |
66 |
Diphenylpyraline hydrochloride
| 1件: Diphenylpyraline Diphenylpyraline | 0件: | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
67 |
Duloxetine hydrochloride
| 1件: Duloxetine Duloxetine | 3件: Cymbalta Cymbalta; DULOXETINE; Duloxetine hydrochloride; | 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 |
68 |
Deferoxamine mesylate
| 1件: Deferoxamine Deferoxamine | 2件: Deferoxamine Deferoxamine; Desferal; | - | - | 3件: 46 46, 284, 286 |
69 |
Dexmedetomidine hydrochloride
| 1件: Dexmedetomidine Dexmedetomidine | 4件: Dexdor Dexdor; DEXMEDETOMIDINA; DEXMEDETOMIDINE; DEXMEDETOMIDINE HYDROCHLORIDE; | 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 13件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 |
70 |
Dydrogesterone
| 1件: Dydrogesterone Dydrogesterone | 1件: DYDROGESTERONE DYDROGESTERONE; | 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 |
71 |
Deslanoside
| - | 0件: | - | - | - |
72 |
Daunorubicin hydrochloride
| 1件: Daunorubicin Daunorubicin | 1件: Daunorubicin Daunorubicin; | 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 65 65 |
73 |
Difluprednate
| - | 0件: | - | - | - |
74 |
Droxidopa
| 1件: Droxidopa Droxidopa | 4件: DOPS DOPS; Droxidopa; L-DOPS; Northera; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 5 5, 6, 17, 169, 170 |
75 |
Doxifluridine
| - | 0件: | - | - | - |
76 |
Diflorasone diacetate
| - | 0件: | - | - | - |
77 |
Dibenzthion
| - | 0件: | - | - | - |
78 |
Dinoprost tromethamine
| - | 0件: | - | - | - |
79 |
Dihydrocodeine phosphate
| 1件: Dihydrocodeine Dihydrocodeine | 0件: | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 310 310 |
80 |
Dexamethasone metasulfobenzoate sodium
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
81 |
Dromostanolone propionate
| - | 0件: | - | - | - |
82 |
Dimeticone
| - | 0件: | - | - | - |
83 |
Dothiepin hydrochloride
| - | 0件: | - | - | - |
84 |
Dexamethasone palmitate
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
85 |
Diphenylpyraline teoclate
| 1件: Diphenylpyraline Diphenylpyraline | 0件: | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
86 |
Dexamethasone dipropionate
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
87 |
Dehydrocholic acid
| - | 0件: | - | - | - |
88 |
Darifenacin hydrobromide
| 1件: Darifenacin Darifenacin | 2件: Darifenacin Darifenacin; Emselex; | 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 6 6, 13 |
89 |
Domperidone
| 1件: Domperidone Domperidone | 1件: Domperidone Domperidone; | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 13, 17, 51, 230 |
90 |
Doxapram hydrochloride
| - | 0件: | - | - | - |
91 |
Dexamethasone valerate
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; DEXAMETHASONE SODIUM PHOSPHATE; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
92 |
Doxycycline hyclate
| 1件: Doxycycline Doxycycline | 4件: Doxycyclin Doxycyclin; Doxycycline; Doxycycline Hyclate; Doxycycline Tablets; | - | - | 16件: 13 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
93 |
Dicloxacillin sodium
| 1件: Dicloxacillin Dicloxacillin | 1件: DICLOXACILLIN DICLOXACILLIN; | - | - | 1件: 299 299 |
94 |
Docetaxel
| - | 0件: | - | - | - |
95 |
Dexamethasone acetate
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
96 |
Dihydroergotamine mesylate
| - | 0件: | - | - | - |
97 |
Desmopressin acetate
| 1件: Desmopressin Desmopressin | 5件: DDAVP DDAVP; Desmopressin; Desmopressin acetate; Desmopressine; Minirin; | 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 6件: 6 6, 64, 72, 75, 225, 288 |
98 |
Diatrizoic acid
| - | 0件: | - | - | - |
99 |
Dantrolene sodium
| 1件: Dantrolene Dantrolene | 2件: Dantrolene Dantrolene; Dantrolene sodium; | - | - | 2件: 13 13, 233 |
100 |
Doxylamine succinate
| - | 0件: | - | - | - |
101 |
Dantrolene
| 1件: Dantrolene Dantrolene | 2件: Dantrolene Dantrolene; Dantrolene sodium; | - | - | 2件: 13 13, 233 |
102 |
Dicloxacillin
| 1件: Dicloxacillin Dicloxacillin | 1件: DICLOXACILLIN DICLOXACILLIN; | - | - | 1件: 299 299 |
103 |
Dipivefrin
| 1件: Dipivefrin Dipivefrin | 2件: Dipivefrin Dipivefrin; Dipivefrine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
104 |
Desogestrel
| 1件: Desogestrel Desogestrel | 2件: Desogestrel Desogestrel; Désogestrel; | 2件: ESR1 ESR1, PGR 💬 | 11件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 230 230 |
105 |
Diethyltoluamide
| - | 0件: | - | - | - |
106 |
Diphenhydramine salicylate
| 1件: Diphenhydramine Diphenhydramine | 2件: Diphenhydramine Diphenhydramine; Diphenhydramine hydrochloride; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
107 |
Diloxanide furoate
| - | 0件: | - | - | - |
108 |
Dronedarone
| - | 0件: | - | - | - |
109 |
Dimetacrine
| - | 0件: | - | - | - |
110 |
Dexamethasone acefurate
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
111 |
Dexamethasone beloxil
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
112 |
Dinoprostone betadex
| - | 0件: | - | - | - |
113 |
Diphenhydramine tannate
| 1件: Diphenhydramine Diphenhydramine | 2件: Diphenhydramine Diphenhydramine; Diphenhydramine hydrochloride; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
114 |
Diphenhydramine laurylsulfate
| 1件: Diphenhydramine Diphenhydramine | 2件: Diphenhydramine Diphenhydramine; Diphenhydramine hydrochloride; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
115 |
Daclizumab
| 1件: Daclizumab Daclizumab | 3件: Daclizumab Daclizumab; Zenapax; Zinbryta; | 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 8件: 13 13, 56, 60, 65, 97, 107, 283, 284 |
116 |
Dalbavancin
| - | 0件: | - | - | - |
117 |
Dapiprazole hydrochloride
| - | 0件: | - | - | - |
118 |
Darapladib
| - | 0件: | - | - | - |
119 |
Darbepoetin alfa
| - | 0件: | - | - | - |
120 |
Darifenacin
| 1件: Darifenacin Darifenacin | 2件: Darifenacin Darifenacin; Emselex; | 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 6 6, 13 |
121 |
Darodipine
| - | 0件: | - | - | - |
122 |
Darunavir
| 1件: Darunavir Darunavir | 1件: Darunavir Darunavir; | - | - | 1件: 2 2 |
123 |
Dasatinib
| 1件: Dasatinib Dasatinib | 1件: Dasatinib Dasatinib; | 8件: ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 | 77件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 2件: 51 51, 85 |
124 |
Dazoxiben hydrochloride
| - | 0件: | - | - | - |
125 |
Decitabine
| 1件: Decitabine Decitabine | 1件: Decitabine Decitabine; | 3件: DNMT1 DNMT1, DNMT3A, DNMT3B 💬 | 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer 💬 | 3件: 13 13, 60, 63 |
126 |
Decoquinate
| - | 0件: | - | - | - |
127 |
Dectaflur
| - | 0件: | - | - | - |
128 |
Deferasirox
| 1件: Deferasirox Deferasirox | 2件: DEFERASIROX DEFERASIROX; EXJADE; | - | - | 3件: 254 254, 284, 286 |
129 |
Deferoxamine
| 1件: Deferoxamine Deferoxamine | 2件: Deferoxamine Deferoxamine; DESFERAL; | - | - | 3件: 46 46, 284, 286 |
130 |
Deflazacort
| 1件: Deflazacort Deflazacort | 1件: Deflazacort Deflazacort; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 30 30, 113 |
131 |
Demeclocycline
| - | 0件: | - | - | - |
132 |
Denileukin diftitox
| - | 0件: | - | - | - |
133 |
Denosumab
| 1件: Denosumab Denosumab | 3件: Denosumab Denosumab; Prolia; XGEVA; | 1件: TNFSF11 TNFSF11 💬 | 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 7件: 46 46, 50, 93, 95, 96, 274, 299 |
134 |
Depreotide
| - | 0件: | - | - | - |
135 |
Deracoxib
| - | 0件: | - | - | - |
136 |
Desirudin
| - | 0件: | - | - | - |
137 |
Desloratadine
| 1件: Desloratadine Desloratadine | 1件: Desloratadine Desloratadine; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
138 |
Deslorelin
| - | 0件: | - | - | - |
139 |
Desmoteplase
| - | 0件: | - | - | - |
140 |
Desonide
| - | 0件: | - | - | - |
141 |
Desoximetasone
| - | 0件: | - | - | - |
142 |
Desoxycorticosterone acetate
| - | 0件: | - | - | - |
143 |
Desoxycorticosterone pivalate
| - | 0件: | - | - | - |
144 |
Dexbrompheniramine maleate
| - | 0件: | - | - | - |
145 |
Dexetimide
| - | 0件: | - | - | - |
146 |
Dexibuprofen
| - | 0件: | - | - | - |
147 |
Dexrazoxane
| 1件: Dexrazoxane Dexrazoxane | 1件: Dexrazoxane Dexrazoxane; | 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 13 13 |
148 |
Doramapimod
| - | 0件: | - | - | - |
149 |
Dextofisopam
| - | 0件: | - | - | - |
150 |
Dextroamphetamine
| - | 0件: | - | - | - |
151 |
Dextromethorphan
| 1件: Dextromethorphan Dextromethorphan | 4件: Dextromethorphan Dextromethorphan; DEXTROMETHORPHAN HYDROBROMIDE; Dextrometorfano; Nuedexta; | 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
152 |
Dextromethorphan polistirex
| 1件: Dextromethorphan Dextromethorphan | 4件: Dextromethorphan Dextromethorphan; Dextromethorphan hydrobromide; Dextrometorfano; Nuedexta; | 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
153 |
Dextrothyroxine sodium
| - | 0件: | - | - | - |
154 |
Dibotermin alfa
| 1件: Dibotermin alfa Dibotermin alfa | 1件: BMP-2 BMP-2; | 1件: BMPR2 BMPR2 💬 | 7件: Axon guidance Axon guidance, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hippo signaling pathway, MicroRNAs in cancer, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 34 34 |
155 |
Dichloralphenazone
| - | 0件: | - | - | - |
156 |
Dichlorvos
| - | 0件: | - | - | - |
157 |
Diclazuril
| - | 0件: | - | - | - |
158 |
Dicumarol
| - | 0件: | - | - | - |
159 |
Dienogest
| - | 0件: | - | - | - |
160 |
Diethylpropion hydrochloride
| - | 0件: | - | - | - |
161 |
Difenoxin
| - | 0件: | - | - | - |
162 |
Dutasteride
| 1件: Dutasteride Dutasteride | 2件: Dutasterida Dutasterida; DUTASTERIDE; | 2件: SRD5A1 SRD5A1, SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 2件: 1 1, 2 |
163 |
Dihydroxyaluminum sodium carbonate
| - | 0件: | - | - | - |
164 |
Diltiazem malate
| 1件: Diltiazem Diltiazem | 2件: Diltiazem Diltiazem; Diltiazem Hydrochloride; | 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 58, 86 |
165 |
Dimethyl fumarate
| 1件: Dimethyl fumarate Dimethyl fumarate | 3件: DIMETHYL FUMARATE DIMETHYL FUMARATE; Dimethylfumarat; TECFIDERA; | 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 5件: 13 13, 49, 51, 86, 296 |
166 |
Dioxybenzone
| - | 0件: | - | - | - |
167 |
Diphenhydramine citrate
| 1件: Diphenhydramine Diphenhydramine | 2件: Diphenhydramine Diphenhydramine; Diphenhydramine hydrochloride; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
168 |
Diphenidol
| - | 0件: | - | - | - |
169 |
Diphenoxylate hydrochloride
| - | 0件: | - | - | - |
170 |
Dipyrithione
| - | 0件: | - | - | - |
171 |
Dirithromycin
| - | 0件: | - | - | - |
172 |
Dirlotapide
| - | 0件: | - | - | - |
173 |
Dobutamine
| 1件: Dobutamine Dobutamine | 2件: Dobutamin Dobutamin; Dobutamine; | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 57 57, 58, 215 |
174 |
Dobutamine lactobionate
| 1件: Dobutamine Dobutamine | 2件: Dobutamin Dobutamin; Dobutamine; | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 57 57, 58, 215 |
175 |
Dobutamine tartrate
| 1件: Dobutamine Dobutamine | 2件: Dobutamin Dobutamin; Dobutamine; | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 57 57, 58, 215 |
176 |
Docosanol
| - | 0件: | - | - | - |
177 |
Domiodol
| - | 0件: | - | - | - |
178 |
Dopexamine
| - | 0件: | - | - | - |
179 |
Doripenem
| 1件: Doripenem Doripenem | 2件: DORIBAX DORIBAX; Doripenem; | - | - | 1件: 299 299 |
180 |
Dornase alfa
| 1件: Dornase alfa Dornase alfa | 3件: Dornase alfa Dornase alfa; Dornase alpha; Pulmozyme; | - | - | 2件: 53 53, 299 |
181 |
Doxofylline
| - | 0件: | - | - | - |
182 |
Doxorubicin
| 1件: Doxorubicin Doxorubicin | 2件: Doxorubicin Doxorubicin; Doxorubicin Hydrochloride; | 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 5件: 26 26, 28, 34, 65, 331 |
183 |
Doxycycline calcium
| 1件: Doxycycline Doxycycline | 4件: Doxycyclin Doxycyclin; Doxycycline; Doxycycline Hyclate; Doxycycline Tablets; | - | - | 16件: 13 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
184 |
Doxycycline fosfatex
| 1件: Doxycycline Doxycycline | 4件: Doxycyclin Doxycyclin; Doxycycline; DOXYCYCLINE HYCLATE; Doxycycline Tablets; | - | - | 16件: 13 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
185 |
Droloxifene
| - | 0件: | - | - | - |
186 |
Drospirenone
| - | 0件: | - | - | - |
187 |
Drotrecogin alfa
| - | 0件: | - | - | - |
188 |
Disodium edetate
| 1件: Edetic acid Edetic acid | 1件: EDTA EDTA; | - | - | 2件: 51 51, 60 |
189 |
Dalfampridine
| 1件: Dalfampridine Dalfampridine | 7件: 4-Aminopyridine 4-Aminopyridine; 4-AP; AMPYRA; Dalfampridine; FAMPRIDINA; FAMPRIDINE; FAMPYRA; | 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 5件: 3 3, 4, 6, 13, 14 |
190 |
Deproteinized serum
| - | 0件: | - | - | - |
191 |
d-Camphor and ethanol
| - | 0件: | - | - | - |
192 |
Dried sodium carbonate
| - | 0件: | - | - | - |
193 |
d-Camphor
| - | 0件: | - | - | - |
194 |
Dasatinib
| 1件: Dasatinib Dasatinib | 1件: Dasatinib Dasatinib; | 8件: ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 | 77件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 2件: 51 51, 85 |
195 |
Dexelvucitabine
| - | 0件: | - | - | - |
196 |
dl-Camphor and ethanol
| - | 0件: | - | - | - |
197 |
Donkey glue
| 1件: Gelatin Gelatin | 3件: Gelatin Gelatin; Gelatine; Sulfur Colloid; | - | - | 7件: 19 19, 28, 62, 78, 97, 269, 299 |
198 |
Difemerine
| - | 0件: | - | - | - |
199 |
Drotaverine
| - | 0件: | - | - | - |
200 |
Diisopromine
| - | 0件: | - | - | - |
201 |
Dantron
| - | 0件: | - | - | - |
202 |
Dextranomer
| - | 0件: | - | - | - |
203 |
Diphenadione
| - | 0件: | - | - | - |
204 |
Ditazole
| - | 0件: | - | - | - |
205 |
Dabigatran etexilate
| 1件: Dabigatran etexilate Dabigatran etexilate | 1件: Dabigatran etexilate Dabigatran etexilate; | 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 1件: 51 51 |
206 |
Dimetofrine
| - | 0件: | - | - | - |
207 |
Dihydralazine
| - | 0件: | - | - | - |
208 |
Dibrompropamidine
| - | 0件: | - | - | - |
209 |
Demegestone
| - | 0件: | - | - | - |
210 |
Demoxytocin
| - | 0件: | - | - | - |
211 |
Droxicam
| - | 0件: | - | - | - |
212 |
Dexketoprofen
| - | 0件: | - | - | - |
213 |
Diacerein
| 1件: Diacerein Diacerein | 1件: Diacerein Diacerein; | - | - | 3件: 36 36, 46, 63 |
214 |
Diamorphine
| - | 0件: | - | - | - |
215 |
Dextromoramide
| - | 0件: | - | - | - |
216 |
Dipyrocetyl
| - | 0件: | - | - | - |
217 |
Doxefazepam
| - | 0件: | - | - | - |
218 |
Difetarsone
| - | 0件: | - | - | - |
219 |
Desaspidin
| - | 0件: | - | - | - |
220 |
Dixanthogen
| - | 0件: | - | - | - |
221 |
Droxypropine
| - | 0件: | - | - | - |
222 |
Dropropizine
| - | 0件: | - | - | - |
223 |
Dimethoxanate
| - | 0件: | - | - | - |
224 |
Deptropine
| - | 0件: | - | - | - |
225 |
Deferiprone
| 1件: Deferiprone Deferiprone | 2件: Deferiprone Deferiprone; Ferriprox; | - | - | 6件: 2 2, 6, 18, 120, 122, 233 |
226 |
Defibrotide sodium
| - | 0件: | - | - | - |
227 |
Danofloxacin
| - | 0件: | - | - | - |
228 |
Dapiprazole
| - | 0件: | - | - | - |
229 |
Daunorubicin
| 1件: Daunorubicin Daunorubicin | 1件: Daunorubicin Daunorubicin; | 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 65 65 |
230 |
Deanol
| 1件: Deanol Deanol | 1件: Deanol Deanol; | - | - | 1件: 6 6 |
231 |
Delapril
| - | 0件: | - | - | - |
232 |
Delavirdine
| - | 0件: | - | - | - |
233 |
Delorazepam
| 1件: Delorazepam Delorazepam | 0件: | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 6 6, 46, 97 |
234 |
Deltamethrin
| - | 0件: | - | - | - |
235 |
Desipramine
| 1件: Desipramine Desipramine | 1件: Desipramine Desipramine; | 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 120 120, 156 |
236 |
Desoxycortone
| - | 0件: | - | - | - |
237 |
Desvenlafaxine
| - | 0件: | - | - | - |
238 |
Detomidine
| - | 0件: | - | - | - |
239 |
Dexamethasone isonicotinate
| - | 0件: | - | - | - |
240 |
Dexchlorpheniramine
| 2件: Chlorpheniramine Chlorpheniramine, Dexchlorpheniramine | 2件: Clorfenamina Clorfenamina; Dexchlorpheniramine; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 3件: 13 13, 14, 49 |
241 |
Dexfenfluramine
| - | 0件: | - | - | - |
242 |
Dexmethylphenidate
| - | 0件: | - | - | - |
243 |
Dextropropoxyphene
| - | 0件: | - | - | - |
244 |
Diacetylmorphine hydrochloride
| - | 0件: | - | - | - |
245 |
Dibekacin
| - | 0件: | - | - | - |
246 |
Dibenzepin
| - | 0件: | - | - | - |
247 |
Diclofenac
| 1件: Diclofenac Diclofenac | 3件: Diclofenac Diclofenac; Diclofenac Sodium; Diclofenac SR; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 5件: 13 13, 34, 46, 78, 271 |
248 |
Dicycloverine
| - | 0件: | - | - | - |
249 |
Dihexyverine
| - | 0件: | - | - | - |
250 |
Diethylcarbamazine
| - | 0件: | - | - | - |
251 |
Diflorasone
| - | 0件: | - | - | - |
252 |
Difloxacin
| - | 0件: | - | - | - |
253 |
Dihydrocodeine
| 1件: Dihydrocodeine Dihydrocodeine | 0件: | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 310 310 |
254 |
Dihydroergocristine
| - | 0件: | - | - | - |
255 |
Dihydroergocryptine
| - | 0件: | - | - | - |
256 |
Dihydroergotamine
| - | 0件: | - | - | - |
257 |
Dihydroergotoxine
| 1件: Dihydroergotoxine Dihydroergotoxine | 1件: Dihydroergotoxine Dihydroergotoxine; | - | - | 1件: 6 6 |
258 |
Dihydrostreptomycin
| - | 0件: | - | - | - |
259 |
Dihydroxyacetone
| - | 0件: | - | - | - |
260 |
Dilazep
| - | 0件: | - | - | - |
261 |
Diloxanide
| - | 0件: | - | - | - |
262 |
Diltiazem
| 1件: Diltiazem Diltiazem | 2件: Diltiazem Diltiazem; Diltiazem Hydrochloride; | 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 58, 86 |
263 |
Dimefline
| - | 0件: | - | - | - |
264 |
Dimemorfan
| - | 0件: | - | - | - |
265 |
Dimetindene
| - | 0件: | - | - | - |
266 |
Dimetotiazine
| - | 0件: | - | - | - |
267 |
Diosmin
| 1件: Diosmin Diosmin | 1件: DIOSMIN DIOSMIN; | - | - | 1件: 265 265 |
268 |
Diphenoxylate
| - | 0件: | - | - | - |
269 |
Diphenylpyraline
| 1件: Diphenylpyraline Diphenylpyraline | 0件: | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
270 |
Diprenorphine
| - | 0件: | - | - | - |
271 |
Dixyrazine
| - | 0件: | - | - | - |
272 |
Docetaxel
| - | 0件: | - | - | - |
273 |
Dolasetron
| - | 0件: | - | - | - |
274 |
Domperidone maleate
| 1件: Domperidone Domperidone | 1件: Domperidone Domperidone; | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 13, 17, 51, 230 |
275 |
Donepezil
| 1件: Donepezil Donepezil | 3件: ARICEPT ARICEPT; Donepezil; Donepezil hydrochloride; | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 9件: 5 5, 6, 13, 46, 78, 124, 127, 156, 206 |
276 |
Dopamine
| 1件: Dopamine Dopamine | 2件: Dopamina Dopamina; Dopamine; | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 4件: 6 6, 7, 74, 299 |
277 |
Dorzolamide
| 1件: Dorzolamide Dorzolamide | 1件: Dorzolamide Dorzolamide; | 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 90 90 |
278 |
Dosulepin
| - | 0件: | - | - | - |
279 |
Doxapram
| - | 0件: | - | - | - |
280 |
Doxazosin
| 1件: Doxazosin Doxazosin | 2件: CARDURA CARDURA; DOXAZOSIN; | 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 57 57, 67 |
281 |
Doxepin
| 1件: Doxepin Doxepin | 1件: Doxepin Doxepin; | 3件: HRH1 HRH1, SLC6A2, SLC6A4 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
282 |
Doxycycline
| 1件: Doxycycline Doxycycline | 4件: Doxycyclin Doxycyclin; Doxycycline; DOXYCYCLINE HYCLATE; Doxycycline Tablets; | - | - | 16件: 13 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
283 |
Doxylamine
| - | 0件: | - | - | - |
284 |
Duloxetine
| 1件: Duloxetine Duloxetine | 3件: CYMBALTA CYMBALTA; Duloxetine; Duloxetine hydrochloride; | 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 |
285 |
Dyclonine
| - | 0件: | - | - | - |
286 |
Deserpidine
| - | 0件: | - | - | - |
287 |
Dacetuzumab
| - | 0件: | - | - | - |
288 |
Dapagliflozin
| 1件: Dapagliflozin Dapagliflozin | 1件: Dapagliflozin Dapagliflozin; | 1件: SLC5A2 SLC5A2 💬 | - | 2件: 49 49, 222 |
289 |
Darinaparsin
| - | 0件: | - | - | - |
290 |
Deferitrin
| - | 0件: | - | - | - |
291 |
Degarelix
| - | 0件: | - | - | - |
292 |
Dexlansoprazole
| 1件: Dexlansoprazole Dexlansoprazole | 1件: Dexlansoprazole Dexlansoprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 98 98 |
293 |
Delafloxacin
| - | 0件: | - | - | - |
294 |
Denenicokin
| - | 0件: | - | - | - |
295 |
Dutogliptin
| - | 0件: | - | - | - |
296 |
Dulanermin
| - | 0件: | - | - | - |
297 |
Dirucotide
| 1件: Dirucotide Dirucotide | 1件: Dirucotide Dirucotide; | - | - | 1件: 13 13 |
298 |
Davunetide
| 1件: Davunetide Davunetide | 1件: Davunetide Davunetide; | - | - | 3件: 5 5, 7, 127 |
299 |
Danegaptide
| - | 0件: | - | - | - |
300 |
Davalintide
| - | 0件: | - | - | - |
301 |
Dilmapimod
| - | 0件: | - | - | - |
302 |
Dinaciclib
| - | 0件: | - | - | - |
303 |
Duvoglustat
| 1件: Duvoglustat Duvoglustat | 3件: 1-deoxynojirimycin 1-deoxynojirimycin; Deoxynojirimycin; Duvoglustat; | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
304 |
Dabigatran
| 1件: Dabigatran Dabigatran | 1件: Dabigatran Dabigatran; | 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 4件: 51 51, 85, 91, 124 |
305 |
Dalcetrapib
| - | 0件: | - | - | - |
306 |
Dalotuzumab
| - | 0件: | - | - | - |
307 |
Delamanid
| - | 0件: | - | - | - |
308 |
Dacomitinib
| - | 0件: | - | - | - |
309 |
Danoprevir
| - | 0件: | - | - | - |
310 |
Dexpramipexole
| 1件: Dexpramipexole Dexpramipexole | 1件: Dexpramipexole Dexpramipexole; | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
311 |
Dulaglutide
| 1件: Dulaglutide Dulaglutide | 2件: Dulaglutide Dulaglutide; Trulicity; | 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 13 13, 299 |
312 |
Dabrafenib
| 1件: Dabrafenib Dabrafenib | 1件: Dabrafenib Dabrafenib; | 1件: BRAF BRAF 💬 | 44件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Bladder cancer, Breast cancer, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Renal cell carcinoma, Serotonergic synapse, Thyroid cancer, Vascular smooth muscle contraction, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 |
313 |
Daclatasvir
| - | 0件: | - | - | - |
314 |
Dolutegravir
| 1件: Dolutegravir Dolutegravir | 2件: Dolutegravir Dolutegravir; Triumeq; | - | - | 2件: 2 2, 265 |
315 |
Dalantercept
| - | 0件: | - | - | - |
316 |
Dasolampanel etibutil
| - | 0件: | - | - | - |
317 |
Delanzomib
| - | 0件: | - | - | - |
318 |
Dexmecamylamine
| - | 0件: | - | - | - |
319 |
Drisapersen
| 1件: Drisapersen Drisapersen | 1件: Drisapersen Drisapersen; | 1件: DMD DMD 💬 | 4件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 |
320 |
Delparantag
| - | 0件: | - | - | - |
321 |
Dusigitumab
| - | 0件: | - | - | - |
322 |
Demcizumab
| - | 0件: | - | - | - |
323 |
Dupilumab
| 1件: Dupilumab Dupilumab | 2件: DUPILUMAB DUPILUMAB; Dupixent; | 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 4件: 51 51, 98, 160, 162 |
324 |
Danirixin
| - | 0件: | - | - | - |
325 |
Deferitazole
| 1件: Deferitazole Deferitazole | 1件: Deferitazole Deferitazole; | - | - | 1件: 284 284 |
326 |
Dianexin
| - | 0件: | - | - | - |
327 |
Delcasertib
| - | 0件: | - | - | - |
328 |
Dacomitinib
| - | 0件: | - | - | - |
329 |
Dactolisib
| - | 0件: | - | - | - |
330 |
Dasabuvir
| - | 0件: | - | - | - |
331 |
Deleobuvir
| - | 0件: | - | - | - |
332 |
Duvelisib
| - | 0件: | - | - | - |
333 |
Dinutuximab
| - | 0件: | - | - | - |
334 |
Decernotinib
| - | 0件: | - | - | - |
335 |
Defactinib
| - | 0件: | - | - | - |
336 |
Dianhydrogalactitol
| - | 0件: | - | - | - |
337 |
Doravirine
| 1件: Doravirine Doravirine | 1件: Doravirine Doravirine; | - | - | 1件: 265 265 |
338 |
Dasotraline
| - | 0件: | - | - | - |
339 |
Deutetrabenazine
| 1件: Deutetrabenazine Deutetrabenazine | 1件: Deutetrabenazine Deutetrabenazine; | 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
340 |
Damoctocog alfa pegol
| - | 0件: | - | - | - |
341 |
Daratumumab
| 1件: Daratumumab Daratumumab | 2件: Daratumumab Daratumumab; Darzalex; | 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 5件: 16 16, 28, 49, 63, 222 |
342 |
Deoxycholic acid
| 1件: Deoxycholic acid Deoxycholic acid | 1件: Kybella Kybella; | - | - | 1件: 34 34 |
343 |
Durvalumab
| 1件: Durvalumab Durvalumab | 1件: Durvalumab Durvalumab; | 1件: CD274 CD274 💬 | 2件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | 1件: 85 85 |
344 |
Desfesoterodine
| - | 0件: | - | - | - |
345 |
Daprodustat
| - | 0件: | - | - | - |
346 |
Decoglurant
| - | 0件: | - | - | - |
347 |
Dapansutrile
| - | 0件: | - | - | - |
348 |
Dexisometheptene mucate
| - | 0件: | - | - | - |
349 |
Dezapelisib
| - | 0件: | - | - | - |
350 |
Depatuxizumab
| - | 0件: | - | - | - |
351 |
Depatuxizumab mafodotin
| - | 0件: | - | - | - |
352 |
Darolutamide
| - | 0件: | - | - | - |
353 |
Delgocitinib
| - | 0件: | - | - | - |
354 |
Domagrozumab
| 1件: Domagrozumab Domagrozumab | 1件: PF-06252616 PF-06252616; | 1件: MSTN MSTN 💬 | 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 113 113 |
355 |
Dotinurad
| - | 0件: | - | - | - |
356 |
Difelikefalin
| - | 0件: | - | - | - |
357 |
Diroximel fumarate
| 1件: Diroximel fumarate Diroximel fumarate | 1件: Diroximel fumarate Diroximel fumarate; | - | - | 1件: 13 13 |
358 |
Dolcanatide
| - | 0件: | - | - | - |
359 |
Dapivirine
| - | 0件: | - | - | - |
360 |
Difamilast
| - | 0件: | - | - | - |
361 |
Dorzagliatin
| - | 0件: | - | - | - |
362 |
Dasiglucagon
| - | 0件: | - | - | - |
363 |
Dostarlimab
| - | 0件: | - | - | - |
364 |
Duvortuxizumab
| - | 0件: | - | - | - |
365 |
Darvadstrocel
| 1件: Darvadstrocel Darvadstrocel | 2件: Alofisel Alofisel; DARVADSTROCEL; | - | - | 1件: 96 96 |
366 |
Deutivacaftor
| 1件: Deutivacaftor Deutivacaftor | 1件: DEUTIVACAFTOR DEUTIVACAFTOR; | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
367 |
Dezamizumab
| 1件: Dezamizumab Dezamizumab | 1件: Dezamizumab Dezamizumab; | 1件: APCS APCS 💬 | - | 1件: 28 28 |
368 |
Donanemab
| - | 0件: | - | - | - |
369 |
Durlobactam
| - | 0件: | - | - | - |
370 |
Danicopan
| 1件: Danicopan Danicopan | 1件: DANICOPAN DANICOPAN; | 1件: CFD CFD 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 2件: 62 62, 222 |
371 |
Dilpacimab
| - | 0件: | - | - | - |
372 |
Dubermatinib
| - | 0件: | - | - | - |
373 |
Duligotuzumab
| - | 0件: | - | - | - |
374 |
Dusquetide
| - | 0件: | - | - | - |
375 |
Daxdilimab
| - | 0件: | - | - | - |
376 |
Dirocaftor
| - | 0件: | - | - | - |
377 |
Deucravacitinib
| 1件: Deucravacitinib Deucravacitinib | 1件: Deucravacitinib Deucravacitinib; | 1件: TYK2 TYK2 💬 | 16件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis 💬 | 2件: 96 96, 97 |
378 |
Dengue tetravalent vaccine, live
| - | 0件: | - | - | - |